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I-SceI inducible HPRT Mutation Assay
Construction of cells with a functional but I-SceI-cleavable HPRT gene (clone 5.2.1) from human fibrosarcoma (HT1080) cells will be described in detail elsewhere. Briefly, an 18 bp I-SceI recognition site was inserted into exon 6 of the hypoxanthine phosphoribosyltransferase (HPRT) gene using a gene targeting procedure while retaining HPRT function. To assay for I-SceI induced loss of HPRT function, clone 5.2.1 was transfected with an I-SceI or a GFP expression plasmid in 6-well plates 48h after the siRNA knockdowns.
The transfection efficiencies were determined after 12h by flow cytometry.
The cells were expanded to 100 mm petri dishes after 24h and were kept in non-selective medium. After 5 days, 10 4 cells were seeded in triplicate into 100 mm Petri dishes for 12 h and fed with complete medium containing 15µM
freshly prepared 6-TG. The plating efficiency was determined similarly, by culturing 10 3 cells in the absence of 6-TG. After 10-14 days of culturing,
HPRT negative cell colonies were visualised by staining with Brilliant Blue R Concentrate (Sigma).
The mutation frequency was determined by dividing the number of 6-TGresistant (HPRT negative) colonies by the total number of cells plated after being corrected for the colony-forming ability. To determine the mutation sequence, independent single cell colonies (30 colonies from each background) were isolated in 24-well plates, genomic DNA was extracted and the I-SceI site within the exon 6 was PCR amplified. The PCR products were sequenced (Sanger Sequencing) using the primers flanking the I-SceI site.
Sequence alignment was conducted using DNA Data Bank of Japan (DDBJ)
ClustalW program (version 2.1). High fidelity Phusion master mix (x2) (New England BioLabs) was used for PCR amplification across the I-SceI site using forward (GATCCTGCACCTACAAAATCC) and reverse (GCATAGGTAAGGTGAGGAGGTG) primers (Sigma). PCR settings were as follows: 98 °C for 30 s, 30 cycles of 98°C for 10 s, 67°C for 1 min, and 72°C for 1min. Products were visualised on 2 % agarose gel with 0.5 µg/ml ethidium bromide.
qPCR for HPRT I-SceI cleavage efficiency
Genomic DNA was isolated using the Qiagen kit at 0h and 24h after the I-SceI 
Generation of cell lines expressing wild-type or methyltransferase dead SETD2
Site-directed mutagenesis primers were designed so that the SETD2 cDNA was mutated from the original sequence (AGAAACCGTCTCCAGTCTGTT) to the sequence AGGAATCGGCTGCAATCCGTG without changing any amino acid. The new cDNA is resistant to SETD2 siRNA#3 because it is refractory to siRNA hybridisation. The refractory cDNA was then mutated to abolish the methyltransferase activity at amino acid 1625 (R to G) and 1631 (C to A) by a two-step mutagenesis. Primers for site-directed mutagenesis are listed below: SS1/SS2 for R1625G, and SS3/SS4 for C1631A.
SS1(CTCAAAAAGGAAATTGCTCTGGTTTCATGAATCACAGCTGT) SS2(ACAGCTGTGATTCATGAAACCAGAGCAATTTCCTTTTTGAG) SS3(CTCGTTTCATGAATCACAGCGCTGAACCAAATTGTGAAAC) SS4(GTTTCACAATTTGGTTCAGCGCTGATTCATGAAACGAG)
U2OS-Flp-In/T-Rex/DRGFP cells and pDESTfrtto plasmid as described later were used to generate stable cell lines expressing SETD2 cDNA. U2OS-FlpIn/T-Rex/DRGFP cells were co-transfected with the resulting SETD2 expression plasmid and pOG44 (Invitrogen) in a ratio of 1:9 using Fugene transfection reagent (Promega). 48 hours after transfection, cells were split and stable integrants were selected for by 100µg/ml Hygromycin and 15µg/ml Blasticidin. About 20 days after selection, colonies were isolated and expanded individually. Individual colonies were tested for SETD2 expression in response to Doxycyline by Western blotting. Cells expressing SETD2 under the control of the T-REx system were subsequently subjected to treatments.
Generation of inducible KDM4A over-expression cell lines
The U2OS-Flp-In/T-Rex cell line was originally generated in the laboratory of Camptothecin (CPT) were purchased from Sigma. Ionising radiation (IR) was carried out by a caesium-137irradiator at dose rate of 1.87Gy/min. Colonies were allowed to form for up to 14 days. Cells were then fixed and stained with Brilliant Blue (Sigma) and numbers of colonies were counted. Plating efficiency (PE) and surviving fraction (SF) were calculated according to (Franken et al., 2006) , where PE=number of colonies formed without treatment/number of cell seeded, and SF=number of colonies formed after treatment/(number of cell seeded×PE).
Western blotting
For histone western blots, proteins from whole cell lysates were separated by NuPAGE Bis-Tris gel (Invitrogen) and transferred to a nitrocellulose membrane (0.2µm pore size) (Invitrogen). For western blot analysis of other proteins, whole cell lysate were separated by NuPAGE Tris-Acetate or BisTris gel (Invitrogen) and transferred to a PVDF membrane (0.45µm pore size) (Invitrogen). After blocking, the membranes were incubated with appropriate primary antibodies at 4°C overnight followed by secondary antibodies at room temperature for 1 hour. Imaging and quantification of the amount of protein was performed by the Odyssey Infrared imaging system (LI-COR).
Primary antibodies used for western blotting are listed below: SETD2 Secondary Alexa Fluor antibodies were purchased from Invitrogen.
Co-Immunoprecipitation
U2OS cells were undamaged or damaged with either 15 uM camptothecin or 6 Gy IR, and allowed to repair for 4 and 2 hours respectively. Cells were lysed and pre-cleared with anti-rabbit serum and incubated overnight with 2-3ug of indicated antibody for immunoprecipitations at 4⁰C overnight. Antibodies used for co-IP were: H3K36me3 (Abcam ab 9050) and LEDGF (Bethyl A300-847A).
Protein A beads were added to and incubated for further 2 hours. Beads were washed with 150mM salt buffers and the resulting eluate was subjected to electrophoresis and analysed by immunoblotting. Western blots were incubated with indicated antibodies at 1:1000 dilution and secondary HRPconjugated antibodies at 1:3000 dilution. 
HR and NHEJ Reporter assays

ChIP analysis at I-SceI resection sites.
Chromatin immunoprecipitations were performed as previously described (Zalmas et al., 2013) . Briefly, U2OS DR-GFP cells were transfected with 2µg 
UV laser micro-irradiation
Performed as indicated in (Suzuki et al., 2011 CAUGUCAUGUGUCACAUCUtt. 48 hours after transfection, cells were treated or not with 300nM of 4-hydroxytamoxifen (Sigma; H7904) for 4h. DNA was next purified using Qiagen DNeasy kit according to manufacturer instruction (the Rnase A incubation step was added as recommended by the manufacturer). Single strand DNA generated at an AsiSI induced DSB was analyzed using the procedure described in (Zhou et al., 2014) , with the following modifications. Briefly, for each sample, 100ng of extracted DNA was subjected to an RNAseH treatment for 15 min, and digested in 30µL with 16
Units of BanI, or mock digested (no enzyme) at 37°C overnight. Samples were heat inactivated at 65°C, and analyzed by qPCR. qPCR was performed on Biorad Device using 2µL of digested or mock digested samples, with the Takara 
ChIP analysis at AsiSI restriction sites
ChIP assays were carried out according to the protocol described in ( 
